/ print page1984-1989 |
University of Greifswald | Diploma in Pharmacy, Experimental Pharmacology and Toxicology |  |
| 1989-1990 | Central Institute for Cancer Research Berlin | Clinical Pharmacology, Clinical Pharmacology and clinical trial methodology | |
| 1991-1994 | German Cancer Research Centre Heidelberg and Max-Delbrück-Center for Molecular Medicine Berlin | Ph. D. Student Experimental Oncology | |
| Investigations on mechanism of action of new platinum and other metal complexes for cancer chemotherapy. Development and characterization of human sarcoma models. Investigations on the phenomenon of multidrug resistance, markers of resistance, and correlation with clinical outcome. | |||
| 1995 | Schering AG Berlin | Postdoctoral Training Investigations on tumor angiogenesis | |
| 1996 | University of Pittsburgh School of Medicine Department of Pharmacology | Postdoctoral Training Investigations on redox regulation and cell death | |
| 1997-2009 | Schering AG Berlin Bayer-Schering Pharma AG | Group leader in Oncology Research | |
| Investigations on novel steroid hormone receptor antagonists and antihormone resistance. Development of novel chemotherapeutics, targeted drugs, and protein therapeutics for the treatment of cancer. Project leader in translational and biomarker research. Project work in tumor imaging and small animal imaging center. | |||
Copyright © 2007 of EPO GmbH - All rights reserved. 16. März 2010.